Final Program

FRIDAY • MAY 13 5
imaging. Lectures will be image rich and focus on key imaging findings, differential
diagnoses, and potential pitfalls. Topics will cover a broad range of chest disease
and will be relevant to trainees, generalists, and specialists, alike. At the
conclusion of the course, learners will have increased knowledge about thoracic
imaging and be able to apply this knowledge to their respective practices.
Chairing: J.P. Kanne, MD, Madison, WI
C.C. Wu, MD, Houston, TX
8:00 Imaging of Small Airways Diseases
T.S. Henry, MD, San Francisco, CA
8:30 Imaging of Large Airways Diseases
S. Rossi, MD, Buenos Aires, Argentina
9:00 Imaging of Pulmonary Vascular Diseases
J.P. Kanne, MD, Madison, WI
9:30 Pulmonary Thromboembolism
C. Schaefer-Prokop, MD, Nijmegen, Netherlands
10:00 Break
10:15 Imaging of Pleural Diseases
C.C. Wu, MD, Houston, TX
10:45 Solitary Pulmonary Nodule
J.H. Chung, MD, Chicago, IL
11:15 Lung Cancer Imaging
A. Leung, MD, Stanford, CA
11:45 LUNCH
12:45 Pulmonary Infection
L. Ketai, MD, Albuquerque, NM
1:15 HRCT of Diffuse Lung Disease
D.A. Lynch, MD, Denver, CO
1:45 Break
2:00 Multidisciplinary Approach to Diffuse Lung Diseases
K.K. Brown, MD, Denver, CO
D.A. Lynch, MD, Denver, CO
S. Groshong, MD, Denver, CO
This session and the International Conference are supported by an educational grant from
AstraZeneca LP.
All CME sessions have been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)
and are free of the control of commercial interests.
PG6
BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL
POSTGRADUATE COURSE
CME Credits Available: 7.0
Nursing Contact Hours Available: 8.5
INTERSTITIAL LUNG DISEASE: THE LATEST ON
DIAGNOSIS AND MANAGEMENT
Pre-registration and additional fees required. Continental breakfast and
box lunch included. Attendance is limited.
Member: $350 In-Training Member: $200
Non-Member: $425 In-Training Non-Member: $300
Registrants must bring a laptop to the
course to view the course material.
Assemblies on Clinical Problems; Allergy, Immunology and
Inflammation; Behavioral Science and Health Services Research; Critical
Care; Environmental, Occupational and Population Health; Nursing;
Pulmonary Rehabilitation
8:00 a.m. - 3:55 p.m. MOSCONE CENTER
Room 3016/3018 (West Building, Level 3)
Target Audience
Clinicians, nurses, other allied health staff, researchers, investigators in basic
and clinical science pertinent to interstitial lung disease, sponsors for
research.
Objectives
At the conclusion of this session, the participant will be able to:
• accurately diagnosis patients with specific forms of ILD;
• understand the current concepts in the pathogenesis and genetic aspects of
pulmonary fibrosis and new therapeutic strategies to treat patients with
ILD/pulmonary fibrosis;
• provide better care to the patients with ILD through comprehensive
management strategies.
This course provides an introduction and update on the diagnosis and management
of interstitial lung disease (ILD), with particular attention to the chronic fibrotic ILDs
and sarcoidosis. Discussion of the clinical, radiological, and pathological approaches
to the diagnosis of ILD will be supplemented by case presentations that illustrate the
multidisciplinary nature of diagnosis in action. Additional talks will focus on the
comprehensive management of ILD including novel therapies, symptoms
management, and lung transplantation.
Chairing: G. Raghu, MD, Seattle, WA
L. Richeldi, MD, PhD, Southampton, United Kingdom
8:00 Introduction and Conference Goals
G. Raghu, MD, Seattle, WA
8:05 Interstitial Lung Disease : An Overview and Approach to
Diagnosis
G. Raghu, MD, Seattle, WA
8:30 Imaging in ILD: Clues to Diagnosis
D.A. Lynch, MD, Denver, CO
9:00 Histopathology Features of ILD
J.L. Myers, MD, Ann Arbor, MI
9:25 Connective Tissue Disease for the Pulmonologist in Evaluating
Interstitial Lung Disease: A Rheumatologists View
V. Steen, MD, Washington, DC
9:50 Genetic Predisposition Factors of Pulmonary Fibrosis: Time
for Genetic Screening and Intervention?
I. Noth, MD, Chicago, IL
10:15 Break
10:25 Hypersensitivity Pneumonitis
M. Vasakova, MD, PhD, Prague, Czech Republic
10:50 Pulmonary Fibrosis: Concepts in Pathogenesis and Targets for
Treatment
A.M. Tager, MD, Charlestown, MA
FRIDAY
ATS 2016 • San Francisco